Lenalidomide Plus R-CHOP for CNS Relapse Prophylaxis in Diffuse Large B-cell Lymphoma
Clinical trial NCT04544059 · UNKNOWN
Trial details
- NCT number
- NCT04544059
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2022-10-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.